GMAB

Genmab A/S

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$51.74

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %27.9 / %30

Non-compliant assets / Total market cap %0 / %30

Non-compliant revenue / Total income %9.9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large B-cell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy.

Website

Analysis (Turkish): GMAB Hissesi Caiz mi, Helal mi? Genmab A/S Katılım Analizi